Advertisement

Medtronic

Medtronic, Inc., based in suburban Minneapolis, Minnesota,[1] is the world's largest[2] medical technology company and is a Fortune 500 company. Medtronic was founded in 1949 in a garage in northeast Minneapolis by Earl Bakken and his brother-in-law Palmer Hermundslie as a medical equipment repair shop.

News:

Minimed announced the launch of the Minimed Duo, a device that combines the glucose sensor and the infusion set into one device, in Europe. Press Release

FDA Approves Medtronic Hybrid Closed Loop System

Minimed received FDA approval for its 670G system in September 2016. Expected to ship in Spring of 2017, the 670G automatically adjusts the delivery of your basal insulin based on readings from Minimed's new CGM, the Guardian Sensor 3 and the Guardian Link 3 transmitter. The sensors are said to have a 7-day life span while being continuously monitored by their new diagnostic technology that monitors how the sensor is doing. This is currently the only sensor approved to drive the amount of insulin delivered by a pump.

Comparison of Current Continuous Glucose Monitors (CGMs)

A continuous glucose monitor, also called CGMs, reveals short-term trends in the blood sugar as they happen. You can see the direction your blood sugar is taking in the last 1, 3, 6, 9, 12, or 24 hours, depending on what times the monitor offers. Various companies have already released continuous monitors, with more companies developing theirs every day.

Infusion Set Comparison

Although patch pumps applied directly to the skin are more available, most pumps infuse insulin from a pump reservoir through an infusion set. No single set works well for everyone, so choosing an infusion set can be difficult. The type of set shipped with a new pump is usually one manufactured by the pump company and this set may or may not be the best choice. Fortunately, there are many alternatives to choose from.

Pages

Subscribe to RSS - Medtronic